Biosimilars: A Global Perspective of a New Market - Opportunities, Threats and Critical Strategies 2014: Enterprise
Report / Survey by Thomson Reuters BioWorld, 09/30/2014
Mari Serebrov
Most Recent
Language:
-
- Available Formats
- Availability
- Priced From ( in USD )
-
- Self Extracting File Format
- Immediate download
- $7,995.00
- Add to Cart
Customers Who Bought This Also Bought
-
Biosimilars: A Global Perspective of a New Market - Oppor...
Priced From $3,995.00
About This Item
Full Description
- Interactive PDF of data, projections, and analysis
- >100 deals involving follow-on biologics (FOBs) identified
- 700 biosimilars and 245 companies profiled
- Updates on approvals and pipeline developments
- Analysis of competitive landscape, defensive strategies, and market share
- Market/regulatory analysis of 25 countries in Europe, Asia/Pacific, Latin America, Middle East, Africa, and North America
- Core drivers and IP issues impacting biosimilar growth
- and much more
Single-user version also available.
